|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Han D, Li J, Wang H, Su X, Hou J, Gu Y,
Qian C, Lin Y, Liu X, Huang M, et al: Circular RNA circMTO1 acts as
the sponge of microRNA-9 to suppress hepatocellular carcinoma
progression. Hepatology. 66:1151–1164. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Barrett T and Edgar R: Mining microarray
data at NCBI's Gene Expression Omnibus (GEO)*. Methods
Mol Biol. 338:175–190. 2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Clough E and Barrett T: The Gene
Expression Omnibus Database. Methods Mol Biol. 1418:93–110.
2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Edgar R, Domrachev M and Lash AE: Gene
Expression Omnibus: NCBI gene expression and hybridization array
data repository. Nucleic Acids Res. 30:207–210. 2002.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wei L, Jin Z, Yang S, Xu Y, Zhu Y and Ji
Y: TCGA-assembler 2: Software pipeline for retrieval and processing
of TCGA/CPTAC data. Bioinformatics. 34:1615–1617. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lane AN and Fan TW: Regulation of
mammalian nucleotide metabolism and biosynthesis. Nucleic Acids
Res. 43:2466–2485. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhou Y, Zhou B, Pache L, Chang M,
Khodabakhshi AH, Tanaseichuk O, Benner C and Chanda SK: Metascape
provides a biologist-oriented resource for the analysis of
systems-level datasets. Nat Commun. 10(1523)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8(e82241)2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhou CC, Yang F, Yuan SX, Ma JZ, Liu F,
Yuan JH, Bi FR, Lin KY, Yin JH, Cao GW, et al: Systemic genome
screening identifies the outcome associated focal loss of long
noncoding RNA PRAL in hepatocellular carcinoma. Hepatology.
63:850–863. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Imbeaud S, Ladeiro Y and Zucman-Rossi J:
Identification of novel oncogenes and tumor suppressors in
hepatocellular carcinoma. Semin Liver Dis. 30:75–86.
2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Spangenberg HC, Thimme R and Blum HE:
Targeted therapy for hepatocellular carcinoma. Nat Rev
Gastroenterol Hepatol. 6:423–432. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hangauer MJ, Vaughn IW and McManus MT:
Pervasive transcription of the human genome produces thousands of
previously unidentified long intergenic noncoding RNAs. PLoS Genet.
9(e1003569)2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Consortium EP: ENCODE Project Consortium.
An integrated encyclopedia of DNA elements in the human genome.
Nature. 489:57–74. 2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sigoillot FD, Berkowski JA, Sigoillot SM,
Kotsis DH and Guy HI: Cell cycle-dependent regulation of pyrimidine
biosynthesis. J Biol Chem. 278:3403–3409. 2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Urrego D, Tomczak AP, Zahed F, Stühmer W
and Pardo LA: Potassium channels in cell cycle and cell
proliferation. Philos Trans R Soc Lond B Biol Sci.
369(20130094)2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jia D, Wei L, Guo W, Zha R, Bao M, Chen Z,
Zhao Y, Ge C, Zhao F, Chen T, et al: Genome-wide copy number
analyses identified novel cancer genes in hepatocellular carcinoma.
Hepatology. 54:1227–1236. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chung KY, Cheng IK, Ching AK, Chu JH, Lai
PB and Wong N: Block of proliferation 1 (BOP1) plays an oncogenic
role in hepatocellular carcinoma by promoting
epithelial-to-mesenchymal transition. Hepatology. 54:307–318.
2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cui F, Hu J, Ning S, Tan J and Tang H:
Overexpression of MCM10 promotes cell proliferation and predicts
poor prognosis in prostate cancer. Prostate. 78:1299–1310.
2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Liu Z, Li J, Chen J, Shan Q, Dai H, Xie H,
Zhou L, Xu X and Zheng S: MCM family in HCC: MCM6 indicates adverse
tumor features and poor outcomes and promotes S/G2 cell cycle
progression. BMC Cancer. 18(200)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhuang L, Yang Z and Meng Z: Upregulation
of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in tumor tissues predicted
worse overall survival and disease-free survival in hepatocellular
carcinoma patients. BioMed Res Int. 2018(7897346)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yang Q, Xie B, Tang H, Meng W, Jia C,
Zhang X, Zhang Y, Zhang J, Li H and Fu B: Minichromosome
maintenance 3 promotes hepatocellular carcinoma radioresistance by
activating the NF-κB pathway. J Exp Clin Cancer Res.
38(263)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gao Z, Man X, Li Z, Bi J, Liu X, Li Z, Li
J, Zhang Z and Kong C: PLK1 promotes proliferation and suppresses
apoptosis of renal cell carcinoma cells by phosphorylating MCM3.
Cancer Gene Ther. 27:412–423. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang SM, Ooi LL and Hui KM: Upregulation
of Rac GTPase-activating protein 1 is significantly associated with
the early recurrence of human hepatocellular carcinoma. Clin Cancer
Res. 17:6040–6051. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang C, Wang W, Liu Y, Yong M, Yang Y and
Zhou H: Rac GTPase activating protein 1 promotes oncogenic
progression of epithelial ovarian cancer. Cancer Sci. 109:84–93.
2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Mi S, Lin M, Brouwer-Visser J, Heim J,
Smotkin D, Hebert T, Gunter MJ, Goldberg GL, Zheng D and Huang GS:
RNA-seq Identification of RACGAP1 as a Metastatic Driver in Uterine
Carcinosarcoma. Clin Cancer Res. 22:4676–4686. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Imaoka H, Toiyama Y, Saigusa S, Kawamura
M, Kawamoto A, Okugawa Y, Hiro J, Tanaka K, Inoue Y, Mohri Y, et
al: RacGAP1 expression, increasing tumor malignant potential, as a
predictive biomarker for lymph node metastasis and poor prognosis
in colorectal cancer. Carcinogenesis. 36:346–354. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Saigusa S, Tanaka K, Mohri Y, Ohi M,
Shimura T, Kitajima T, Kondo S, Okugawa Y, Toiyama Y, Inoue Y, et
al: Clinical significance of RacGAP1 expression at the invasive
front of gastric cancer. Gastric Cancer. 18:84–92. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Taguchi A, Rho JH, Yan Q, Zhang Y, Zhao Y,
Xu H, Tripathi SC, Wang H, Brenner DE, Kucherlapati M, et al:
MAPRE1 as a plasma biomarker for early-stage colorectal cancer and
adenomas. Cancer Prev Res (Phila). 8:1112–1119. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kim K, Lee HC, Park JL, Kim M, Kim SY, Noh
SM, Song KS, Kim JC and Kim YS: Epigenetic regulation of
microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer.
Epigenetics. 6:740–751. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Fu JF, Hsu HC and Shih LY: MLL is fused to
EB1 (MAPRE1), which encodes a microtubule-associated protein, in a
patient with acute lymphoblastic leukemia. Genes Chromosomes
Cancer. 43:206–210. 2005.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Chen RX, Song HY, Dong YY, Hu C, Zheng QD,
Xue TC, Liu XH, Zhang Y, Chen J, Ren ZG, et al: Dynamic expression
patterns of differential proteins during early invasion of
hepatocellular carcinoma. PLoS One. 9(e88543)2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Xie T, Li X, Ye F, Lu C, Huang H, Wang F,
Cao X and Zhong C: High KIF2A expression promotes proliferation,
migration and predicts poor prognosis in lung adenocarcinoma.
Biochem Biophys Res Commun. 497:65–72. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhang X, Ma C, Wang Q, Liu J, Tian M, Yuan
Y, Li X and Qu X: Role of KIF2A in the progression and metastasis
of human glioma. Mol Med Rep. 13:1781–1787. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wang J, Ma S, Ma R, Qu X, Liu W, Lv C,
Zhao S and Gong Y: KIF2A silencing inhibits the proliferation and
migration of breast cancer cells and correlates with unfavorable
prognosis in breast cancer. BMC Cancer. 14(461)2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Duan J, Huang W and Shi H: Positive
expression of KIF20A indicates poor prognosis of glioma patients.
OncoTargets Ther. 9:6741–6749. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Stangel D, Erkan M, Buchholz M, Gress T,
Michalski C, Raulefs S, Friess H and Kleeff J: Kif20a inhibition
reduces migration and invasion of pancreatic cancer cells. J Surg
Res. 197:91–100. 2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Tilghman J, Wu H, Sang Y, Shi X,
Guerrero-Cazares H, Quinones-Hinojosa A, Eberhart CG, Laterra J and
Ying M: HMMR maintains the stemness and tumorigenicity of
glioblastoma stem-like cells. Cancer Res. 74:3168–3179.
2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Bidadi B, Liu D, Kalari KR, Rubner M, Hein
A, Beckmann MW, Rack B, Janni W, Fasching PA, Weinshilboum RM, et
al: Pathway-Based Analysis of Genome-Wide Association Data
Identified SNPs in HMMR as Biomarker for Chemotherapy- Induced
Neutropenia in Breast Cancer Patients. Front Pharmacol.
9(158)2018.PubMed/NCBI View Article : Google Scholar
|
